Genexine, Inc. (KOSDAQ: 095700)

Genexine Market Cap

Genexine has a market cap or net worth of 260.72 billion as of October 11, 2024. Its market cap has decreased by -37.29% in one year.

• Market Cap: 260.72B
• Enterprise Value: 276.88B
• Revenue: 5.81B
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: 6,410.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 260.72B, an increase of 139.15%. That is a compound annual growth rate of 5.95%.

Market Cap History

Date	Market Cap	% Change
Oct 11, 2024	261.55B	-36.26%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	3,069.93B	106.72%
Dec 30, 2019	1,485.08B	0.14%